Bone treatments: what to use and when

During a Special Symposium, held on Sunday Sep. 28th at ESMO 2012, on the medical treatment of advanced prostate cancer, Dr Chris Parker, Consultant Clinical Oncologist at the Royal Marsden Hospital NHS Foundation Trust, Sutton, UK, reviewed data for the various existing and emerging bone treatments for prostate cancer and provided his expert opinion regarding how we can best use these agents to improve overall survival (OS) and quality of life (QoL) and to delay SREs and bone metastases. Read more here.